Arginine-Vasopressin Receptor Blocker Conivaptan Reduces Brain Edema and Blood-Brain Barrier Disruption after Experimental Stroke in Mice

Open Access

Peer-reviewed

Research Article

Emil Zeynalov ,

* E-mail: emil.zeynalov@healthonecares.com

Affiliation Swedish Medical Center, Neurotrauma Research, Englewood, Colorado, United States of America
⨯
Susan M. Jones,

Affiliation Swedish Medical Center, Neurotrauma Research, Englewood, Colorado, United States of America
⨯
Jeong-Woo Seo,

Affiliation Swedish Medical Center, Neurotrauma Research, Englewood, Colorado, United States of America
⨯
Lawrence D. Snell,

Affiliation Colorado Neurological Institute, Englewood, Colorado, United States of America
⨯
J. Paul Elliott

Affiliation Colorado Brain and Spine Institute, Englewood, Colorado, United States of America
⨯

Reader Comments (0)

Edema
Is the Subject Area "Edema" applicable to this article?

Thanks for your feedback.
Blood-brain barrier
Is the Subject Area "Blood-brain barrier" applicable to this article?

Thanks for your feedback.
Urine
Is the Subject Area "Urine" applicable to this article?

Thanks for your feedback.
Blood plasma
Is the Subject Area "Blood plasma" applicable to this article?

Thanks for your feedback.
Stroke
Is the Subject Area "Stroke" applicable to this article?

Thanks for your feedback.
Ischemic stroke
Is the Subject Area "Ischemic stroke" applicable to this article?

Thanks for your feedback.
Reperfusion
Is the Subject Area "Reperfusion" applicable to this article?

Thanks for your feedback.
Receptor antagonist therapy
Is the Subject Area "Receptor antagonist therapy" applicable to this article?

Thanks for your feedback.